Abciximab: Clinical Trials

10 trials of Abciximab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 2 withdrawn. 10 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Completed 5, Unknown 3, Withdrawn 2
Phase 11Withdrawn 1
Phase 31Unknown 1

Follow Abciximab: new trials by email Literature Review of Abciximab trials Research Report on Abciximab

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis
Abciximab, Placebo, Intravenous hydration - Sickle Cell Disease, Hb-SS Disease With Vasoocclusive Pain
Phase 2WithdrawnSt. Louis University2013-11-012015-03-26
Exploratory P2 Trial to Evaluate Efficacy and Safety of Clotinab® (Abciximab) in Acute MI Patients
Abciximab, Placebo - Acute Myocardial Infarction
Phase 2UnknownISU Abxis Co., Ltd.1462013-05-012017-03-22
Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients
ALX-0081, ReoPro® - Unstable Angina, Non ST Segment Elevation Myocardial Infarction (NSTEMI)
Phase 2CompletedAblynx, a Sanofi company3642009-09-012023-04-04
Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
Intravenous Glycoprotein inhibitor + ASA, Clopidogrel, Antiplatelet Therapy (ASA, Clopidogrel) - Stable Angina
Phase 2CompletedIcahn School of Medicine at Mount Sinai362007-04-012018-02-14
Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours
Primary angioplasty with stent and abciximab - Acute Myocardial Infarction
Phase 2CompletedAarhus University Hospital Skejby602005-05-012008-05-22
Below Study - Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee
abciximab, stent and drug eluting stent - Patients Above 18 Years
Phase 2UnknownUniversity Hospital Tuebingen2003-09-012006-09-12
ReoPro and Retavase to Treat Acute Stroke
Reopro, Retrovase - Cerebrovascular Accident
Phase 2CompletedNational Institute of Neurological Disorders and Stroke (NINDS)722002-09-242017-07-02
ReoPro and Retavase to Restore Brain Blood Flow After Stroke
Abciximab (ReoPro) and Reteplase (Retavase) - Cerebrovascular Accident
Phase 2CompletedNational Institute of Neurological Disorders and Stroke (NINDS)422002-03-012011-09-21
Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease
Balloon Angioplasty, ReoPro - Arterial Occlusive Diseases
Phase 2 / Phase 3UnknownUniversity Hospital Tuebingen4202002-01-012006-09-12
Stroke Prevention With Abciximab in Carotid Endarterectomy
Abciximab - Carotid Stenosis
Phase 1 / Phase 2WithdrawnUniversity of Rochester2015-12-18

Conditions studied

Angina, Stable (2)  ·  Stroke (2)  ·  Anemia, Sickle Cell (1)  ·  Angina, Unstable (1)  ·  Arterial Occlusive Diseases (1)  ·  Carotid Stenosis (1)  ·  Death (1)  ·  Hemorrhage (1)  ·  Non-ST Elevated Myocardial Infarction (1)  ·  Peripheral Vascular Diseases (1)  ·  Vaso-Occlusive Crises (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (2)  ·  University Hospital Tuebingen (2)  ·  Aarhus University Hospital Skejby (1)  ·  Ablynx, a Sanofi company (1)  ·  ISU Abxis Co., Ltd. (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  St. Louis University (1)  ·  University of Rochester (1)

Countries

United States (5)  ·  Germany (4)  ·  Austria (1)  ·  Belgium (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Israel (1)  ·  Poland (1)  ·  South Korea (1)  ·  Switzerland (1)

Top investigators

Gunnar Tepe, MD (2)  ·  Annapoorna S Kini, MD MRCP (1)  ·  Iris Baumgartner, MD (1)  ·  Josefin-Beate Holz, MD (1)  ·  Myungho Jeong (1)  ·  Steen D. Kristensen, MD (1)  ·  William S Burgin, MD (1)  ·  William S Ferguson, MD (1)